Position in JNJ
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$28,867,754
+$4,491,321 QoQ
Shares Held
113,666
-3.5% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.94%
of 13F equity value
Holder Rank
#608
of 4,664 holders
Holding Since
Jun 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026J.W. COLE ADVISORS, INC. holds $121,333,460 across 13 Drug Manufacturers - General names. JNJ ranks #2 (23.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
30,412 | $36,477,068 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
113,666 | $28,867,754 | |
| 3 | ABBV |
AbbVie Inc.
|
73,916 | $18,600,222 | |
| 4 | MRK |
Merck & Co., Inc.
|
100,135 | $12,867,347 | |
| 5 | AMGN |
Amgen Inc
|
16,509 | $5,978,239 | |
| 6 | PFE |
Pfizer Inc
|
235,737 | $5,676,546 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
30,495 | $3,852,738 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
59,835 | $3,447,692 |
All Filings in JNJ
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $28,867,754 | 113,666 | Shares | Sole | 2026-07-21 | |
| 2025-12-31 | $24,376,433 | 117,789 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $24,277,782 | 130,934 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $19,577,203 | 128,165 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $18,411,888 | 111,022 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $9,111,783 | 63,005 | Shares | Sole | 2025-01-31 | |
| 2024-09-30 | $10,417,378 | 64,281 | Shares | Sole | 2024-10-24 | |
| 2024-06-30 | $8,879,220 | 60,750 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $9,073,620 | 57,359 | Shares | Sole | 2024-04-30 | |
| 2023-12-31 | $9,814,118 | 62,614 | Shares | Sole | 2024-01-31 | |
| 2023-09-30 | $8,500,212 | 54,576 | Shares | Sole | 2023-10-24 | |
| 2023-06-30 | $9,680,933 | 58,488 | Shares | Sole | 2023-07-27 | |
| 2023-03-31 | $9,634,645 | 62,159 | Shares | Sole | 2023-05-03 | |
| 2022-12-31 | $10,308,587 | 58,356 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $9,546,268 | 58,437 | Shares | Sole | 2022-10-31 | |
| 2022-06-30 | $10,273,391 | 57,875 | Shares | Sole | 2022-07-27 | |
| 2022-03-31 | $10,033,344 | 56,612 | Shares | Sole | 2022-06-10 | |
| 2021-12-31 | $10,068,666 | 58,857 | Shares | Sole | 2022-01-25 | |
| 2021-09-30 | $8,816,769 | 54,593 | Shares | Sole | 2021-10-26 | |
| 2021-06-30 | $8,431,722 | 51,182 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $6,573,506 | 39,997 | Shares | Sole | 2021-04-28 | |
| 2020-12-31 | $6,064,953 | 38,537 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $12,871,718 | 86,457 | Shares | Sole | 2020-11-05 | |
| 2020-06-30 | $4,409,875 | 31,358 | Shares | Sole | 2020-08-07 | |
| No filing history on record for this holder in this stock. | ||||||